CatallaxCore
← Back to bills

HB 18-1148

signed

Stage Four Advanced Metastatic Cancer Step Therapy

Plain-English Summary

AI-generated

House Bill 18-1148, also known as the Stage Four Advanced Metastatic Cancer Step Therapy bill, stops health insurance companies from requiring patients with stage four cancer to try less effective treatments before they can access a drug that is best for their condition and approved by the FDA. This means that if a doctor recommends a specific medication based on what’s considered the most effective treatment, the insurance company must cover it immediately without forcing the patient through other steps first. The bill has been signed into law, so it will now protect cancer patients in Colorado from unnecessary delays in their treatment.

Official Summary

The bill prohibits a carrier that issues a health benefit plan that covers treatment for stage four advanced metastatic cancer from requiring a cancer patient to undergo step therapy prior to receiving a drug approved by the United States food and drug administration if use of the approved drug is consistent with best practices for treatment of the cancer and as long as the drug is on the carrier's prescription drug formulary. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.) , Read More

Details

Chamber
House
First action
2018-04-09
Latest action
2018-01-31
Last action desc.
Introduced In House - Assigned to Public Health Care & Human Services
OpenStates
View source ↗

Related Legislation

This bill affects (6)

amends
HB 17-1247(2017A)· failed
Patient Choice Health Care Provider
amends
SB 17-151(2017A)· failed
Consumer Access To Health Care
amends
SB 17-203(2017A)· signed
Prohibit Carrier From Requiring Alternative Drug
amends
SB 17-084(2017A)· failed
Coverage For Drugs In A Health Coverage Plan
amends
HB 17-1318(2017A)· failed
Division Of Insurance Annual Report Pharmaceutical Costs Data
amends
HB 17-1165(2017A)· signed
Department Of Regulatory Agencies Boards Disciplinary Action Resolution Process

Affected by (3)

relates
SB 23-033(2023A)· signed
Medicaid Preauthorization Exemption
relates
HB 23-1130(2023A)· signed
Drug Coverage For Serious Mental Illness
repeals
HB 22-1370(2022A)· signed
Coverage Requirements For Health-care Products

Votes

BILL
2018-03-29 · Senate · passYes: 29 · No: 6 · Other:
BILL
2018-03-29 · Senate · passYes: 57 · No: 6 · Other: